Bladder, Neurogenic Clinical Trial
Official title:
A Phase IIb/III, Multi-centre, Double-blind, Randomised, Placebo-controlled, Dose Ranging Study of Tamsulosin Hydrochloride (Low, Medium and High Dose) as Treatment in Children With Neuropathic Bladder for Three Months
Aim of this study is to evaluate the efficacy and safety of a range of doses of tamsulosin hydrochloride as treatment in children with an elevated detrusor leak point pressure associated with a known neurological deficit
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03593512 -
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
|
N/A | |
Not yet recruiting |
NCT03698721 -
Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate
|
||
Active, not recruiting |
NCT00175123 -
Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele
|
Phase 4 | |
Recruiting |
NCT04738539 -
Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
|
||
Completed |
NCT00591240 -
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
|
N/A | |
Completed |
NCT03908047 -
Functional Changes in the Brain After Tibial Nerve Stimulation: a Pilot Study
|
||
Recruiting |
NCT06337942 -
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
|
N/A | |
Completed |
NCT00340704 -
PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder
|
Phase 2 |